Stephen T. Worland
2022
In 2022, Stephen T. Worland earned a total compensation of $3.8M as President and Chief Executive Officer at eFFECTOR Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $254,295 |
|---|---|
| Option Awards | $2,987,797 |
| Salary | $566,500 |
| Other | $34,460 |
| Total | $3,843,052 |
Worland received $3M in option awards, accounting for 78% of the total pay in 2022.
Worland also received $254.3K in non-equity incentive plan, $566.5K in salary and $34.5K in other compensation.
Rankings
In 2022, Stephen T. Worland's compensation ranked 909th out of 5,625 executives tracked by ExecPay. In other words, Worland earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 909 out of 5,625 | 84th |
Division Manufacturing | 413 out of 3,053 | 87th |
Major group Chemicals And Allied Products | 144 out of 1,380 | 90th |
Industry group Drugs | 130 out of 1,281 | 90th |
Industry Pharmaceutical Preparations | 96 out of 927 | 90th |
Source: SEC filing on May 12, 2023.
Worland's colleagues
We found four more compensation records of executives who worked with Stephen T. Worland at eFFECTOR Therapeutics in 2022.